Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial - Wikidata - awgldk - TriplyDB

Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial

Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial

http://www.wikidata.org/entity/Q34876994

about

Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis.Angiotensin System Blockade Combined With Calcium Channel Blockers Is Superior to Other Combinations in Cardiovascular Protection With Similar Blood Pressure Reduction: A Meta-Analysis in 20,451 Hypertensive Patients.Combination therapy in the treatment of hypertension.

P2860

Q31117990-17186264-6C63-44EF-9BFF-965BFD90E243 Q36061968-396DC960-CA5B-4ADC-B0EA-79F22C2667CB Q53641124-BAD29223-88AF-4EF4-9E2B-982681B150D9 Q55165056-9C4404AD-8EBC-4D0E-B01C-47489CD0EBAF

P2860

Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial

http://www.wikidata.org/entity/Q34876994

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Combination therapy of hyperte ...... ly hypertensive patients trial

@ast

Combination therapy of hyperte ...... ly hypertensive patients trial

@en

Combination therapy of hyperte ...... ly hypertensive patients trial

@nl

type

label

Combination therapy of hyperte ...... ly hypertensive patients trial

@ast

Combination therapy of hyperte ...... ly hypertensive patients trial

@en

Combination therapy of hyperte ...... ly hypertensive patients trial

@nl

prefLabel

Combination therapy of hyperte ...... ly hypertensive patients trial

@ast

Combination therapy of hyperte ...... ly hypertensive patients trial

@en

Combination therapy of hyperte ...... ly hypertensive patients trial

@nl

P1433

Q34876994-A0CE7AA2-5D5D-4250-82ED-ECC4853CCAAE

P1476

Q34876994-FAB19E94-286B-4AE5-B129-D532E74F25FE

P2093

Q34876994-0451402A-4F2A-48E5-8FFE-E08851FE4BE8

Q34876994-40D304BE-35D0-4DE8-9A74-05D02CFACF15

Q34876994-75000276-E8ED-498C-8ADB-3AD12F2ECC85

Q34876994-82276AF9-4542-4742-8E14-437EF8E6A967

Q34876994-89F51DF2-3CB8-4BDB-B587-324292BE80C1

Q34876994-B9FE3A7C-C7C9-4ED1-8BD8-A103E149B07F

Q34876994-D0B46F18-47CA-4D22-BC7B-1FF5D6AEA09B

Q34876994-E768A7D1-C35A-4919-A18B-8467DEF443E4

P2860

Q34876994-199EFA5C-29AA-4CCC-8F94-EC145C49E9E2

Q34876994-2FE35992-71DC-4409-99DA-E2FCD815D592

Q34876994-3184628E-CE5A-4906-8228-B288ED3C4729

Q34876994-40E0DF92-5067-4EC7-BFD8-5EF7078F2B6B

Q34876994-4EB6F7C8-546D-4A6B-A7C6-34AD0ACE98E0

Q34876994-5FA70582-75A9-4232-809E-0B76B1074DE1

Q34876994-7AD6F272-E1DE-4959-8B61-A467AE251A6D

Q34876994-836FB05C-2DBC-4B12-AA7C-28744423D0B2

Q34876994-879F66B9-999A-4F8F-B548-FD85B82D6628

Q34876994-94481A70-5C57-4C63-9F55-03463E9208BA

P2888

Q34876994-13A68E91-EFFC-49B0-ABBD-C10DCC69D9FF

P304

Q34876994-3CCF9F79-A014-4637-9E70-45B116E60762

P31

Q34876994-84C8491C-A136-4DB6-88E0-18552FA63EF8

P356

Q34876994-820A045E-9EC2-4360-88A3-050CC812AF4D

P433

Q34876994-D31FF52C-04F6-413D-A4BD-1EF63C30188A

P478

Q34876994-311BDD1D-5B6B-4FE7-86B0-C3FB2C1F9028

P50

Q34876994-0E90BC04-3781-4BFD-88A7-621157BB1997

Q34876994-AA889C3A-8959-44E5-B73A-3BEE8D61D033

Q34876994-B2A55578-5A35-4F7C-9FCF-B6791A3CDC3E

P577

Q34876994-304AA2E0-97F1-4706-8637-FA908E4CD93A

P5875

Q34876994-FE2CF19B-DF92-49FC-8C12-B1B672D8E734

P698

Q34876994-8E560346-D1A9-4BC0-8BA2-DBCA803001E2

P932

Q34876994-B606EFB2-E584-41BA-B58A-AB2CCE04F236

P356

P1433

Hypertension Research

P1476

Combination therapy of hyperte ...... ly hypertensive patients trial

@en

P2093

COLM Investigators

http://www.w3.org/2001/XMLSchema#string

Hiroaki Matsuoka

http://www.w3.org/2001/XMLSchema#string

Ikuo Saito

http://www.w3.org/2001/XMLSchema#string

Jitsuo Higaki

http://www.w3.org/2001/XMLSchema#string

Kazuaki Shimamoto

http://www.w3.org/2001/XMLSchema#string

Kazuyuki Shimada

http://www.w3.org/2001/XMLSchema#string

Takao Saruta

http://www.w3.org/2001/XMLSchema#string

Toshio Ogihara

http://www.w3.org/2001/XMLSchema#string

P2860

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Treatment of hypertension in patients 80 years of age or older.

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.

Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study

Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.

Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients.

Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients.

P2888

P304

89-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/HR.2014.144

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Satoshi Teramukai

P577

2014-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266151746

http://www.w3.org/2001/XMLSchema#string

P698

25253583

http://www.w3.org/2001/XMLSchema#string

P932

4287656

http://www.w3.org/2001/XMLSchema#string